science

Icotrokinra

Icotrokinra is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Icotrokinra rather than just read about it. In short: Icotrokinra, sold under the brand name Icotyde, is a medication used for the treatment of plaque psoriasis. It is a cyclic peptide that functions as a selective interleukin 23 (IL-23) receptor antagonist.

Key takeaways

Icotrokinra belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Icotrokinra to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Icotrokinra from memory before moving on to harder problems.

Reference excerpt

Icotrokinra, sold under the brand name Icotyde, is a medication used for the treatment of plaque psoriasis. It is a cyclic peptide that functions as a selective interleukin 23 (IL-23) receptor antagonist. It is being developed by Johnson & Johnson as an oral treatment for autoimmune disorders, including plaque psoriasis and ulcerative colitis. Icotrokinra was approved for medical use in the United States in March 2026.

Medical uses Icotrokinra is indicated for the treatment of moderate-to-severe plaque psoriasis in people aged twelve years of age and older who weigh at least 40 kilograms (88 lb) who are candidates for systemic therapy or phototherapy.

Mechanism of action Icotrokinra is a targeted oral peptide that selectively binds to and blocks the interleukin 23 receptor (IL-23R), thereby inhibiting IL-23-mediated signaling. The drug demonstrates high affinity for the human IL-23 receptor with a dissociation constant (KD) of 7.1 pM and inhibits IL-23-induced STAT3 phosphorylation in peripheral blood mononuclear cells with an IC50 of 5.6 pM. The IL-23 pathway plays a central role in the inflammatory cascade underlying various autoimmune conditions, particularly those involving Th17 cells. Unlike injectable biologics that target IL-23 or its receptor, icotrokinra offers the convenience of oral administration while maintaining selective receptor binding.

Clinical trials

Plaque psoriasis The clinical development program for plaque psoriasis includes several Phase III studies:

ICONIC-LEAD The ICONIC-LEAD study is a Phase III, randomized, double-blind, placebo-controlled trial evaluating icotrokinra versus placebo in patients with moderate to severe plaque psoriasis. The study met its co-primary endpoints, with 74% of patients achieving clear or almost clear skin (IGA 0/1) at week 24.

ICONIC-ADVANCE 1 and 2 The ICONIC-ADVANCE 1 and 2 studies are head-to-head Phase III trials comparing icotrokinra to deucravacitinib (Sotyktu) in patients with moderate to severe plaque psoriasis. Both studies met their co-primary endpoints and demonstrated superiority of icotrokinra over deucravacitinib.

ICONIC-TOTAL The Phase 3 ICONIC-TOTAL study showed once daily icotrokinra met the primary endpoint of IGA of 0/1 at week 16 compared to placebo.

Ulcerative colitis

ANTHEM-UC The ANTHEM-UC study is a Phase IIb trial evaluating icotrokinra in adults with moderately to severely active ulcerative colitis. The study met its primary endpoint of clinical response, with patients treated with the highest dose of icotrokinra achieving a response rate of 63.5% at week 12 versus 27% for placebo.

Safety and tolerability Across clinical studies, icotrokinra has demonstrated a favorable safety profile. In Phase III trials for plaque psoriasis, the most common adverse events were upper respiratory tract infections and headache. Pooled safety data from multiple studies showed similar rates of adverse events between icotrokinra and comparator groups.

History Icotrokinra was jointly discovered by Johnson & Johnson (J&J) and Protagonist Therapeutics.

References

Illustrations

Worked examples

Example 1 — a first encounter with Icotrokinra

Start with the simplest possible case. Write down what Icotrokinra claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Icotrokinra before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Icotrokinra ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Icotrokinra

In research: Icotrokinra appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Icotrokinra in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Icotrokinra is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antipsoriatics, Cyclic peptides, Drugs developed by Johnson & Johnson, so understanding it makes those chapters shorter.
In everyday life: Look for Icotrokinra outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Icotrokinra” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Icotrokinra in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Icotrokinra means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Icotrokinra out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Icotrokinra in simple terms?

Why does Icotrokinra matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Icotrokinra?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Icotrokinra.